BioWorld MedTech

June 15, 2011

CerebralRx enters market with vagus nerve stimulation device

CerebralRx, a newly formed spin-off of BioControl Medical (both Yehud, Israel), is hitting the ground running with the launch of its FitNeS vagus nerve stimulation system for epilepsy in Europe. (Medical Device Daily) Read More

Washington roundup: FDA's new nanoscale materials guidance sets bar at 1,000 nm

International report: Medical Care Technologies expands Chinese operations

Device gives hospitals early sense of patient's condition

Financings roundup: UHS to offer $175M of second lien toggle notes

Med-Tech Notes

Agreements/contracts: pSivida amends glaucoma R&D development with Pfizer

HIT roundup: Premier releases PhysicianFocus for performance improvement

Patent watch: Biomoda expands use of assay with new patent

Grants roundup: Precision Medical receives QTDP grant for UI device

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Voyager’s gene therapy reduces tau levels in AD models

BioWorld Science

At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...

Illustration of T cells attacking cancer

GABA signaling linked to immune resistance in some tumors

BioWorld

Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...